| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Revenue | ||||||
43 | 47 | 45 | 44 | 236 | 641 | 600 |
Operating expenses: | ||||||
Research and development (including amounts with related parties) | ||||||
49,785 | 55,718 | 42,044 | 29,153 | 11,434 | 1,595 | 446 |
Selling, general and administrative (including amounts with related parties) | ||||||
18,065 | 42,718 | 57,121 | 95,391 | 227,678 | 4,621 | 2,423 |
Total operating expenses | ||||||
67,850 | 98,436 | 99,165 | 124,544 | 239,112 | 6,216 | - |
Loss from operations | ||||||
-67,807 | -98,389 | -99,120 | -124,500 | -238,876 | -5,575 | - |
Other income (expense): | ||||||
Investment income, net | ||||||
1,642 | 1,857 | 2,665 | 3,097 | 2,988 | 20 | 2 |
Interest expense | ||||||
19 | 433 | 618 | 66 | - | - | - |
Change in fair value of warrant liability | ||||||
- | - | - | - | 1,366 | 158 | -684 |
Interest expense (including amounts to related parties) | ||||||
- | - | - | - | 0 | 471 | 463 |
Other income, net (including amounts with related parties) | ||||||
298 | 236 | 157 | 88 | 77 | 0 | - |
Total other income | ||||||
1,921 | 1,660 | 2,204 | 3,119 | 1,699 | -609 | - |
Loss before income taxes | ||||||
-65,886 | -96,729 | -96,916 | -121,381 | -237,177 | -6,184 | - |
Income tax benefit | ||||||
-97 | -503 | -493 | -572 | -301 | 1 | 1 |
Net loss | ||||||
-65,789 | -96,226 | -96,423 | -120,809 | -236,876 | -6,185 | -2,047 |
Net loss per share: | ||||||
Basic and diluted | ||||||
-0.70 | -1.22 | -1.20 | -1.47 | -3.31 | -0.75 | -2.57 |
Weighted-average number of shares during the period: | ||||||
Basic and diluted | ||||||
94,210 | 79,132 | 80,583 | 81,979 | 71,519 | 8,246 | 797 |